NIH program to make vaccines against pathogens that can trigger pandemics uses approach pioneered in last century ...

Researchers describe a concentric supraparticle system that protects and delivers RNA therapeutics for gene silencing in ...

Moderna stock crumbled Thursday after the biotech company missed sales estimates for its two products, Spikevax and mResvia.

Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% ...

Vaccines are saving millions of lives world over, but in India, we continue to experience critical challenges in implementing ...

As the world marks World Immunization Week, attention turns once again to the lifesaving power of vaccines.Amid headlines about rising cases of measles, falling vaccination rates and growing vaccine ...

The potential change outlined in a statement would require all new vaccines to undergo placebo testing, sparking concerns ...

Research teams across Canada are now building on homegrown innovation to expand the potential of RNA vaccines beyond ...

In this phase 1 randomized controlled trial, urticaria was reported in several participants who received a messenger RNA ...

The Boehringer Ingelheim Foundation is providing 600,000 Euros in funding for basic research into new approaches to the treatment of liver fibrosis and fatty liver hepatitis.

Banning mRNA technology in response to the many missteps of public health officials during the pandemic is a textbook example ...